Acostic Neuroma (Auditory Nerve Tumor) – Drugs In Development, 2024
Powered by ![]()
Unlock hidden opportunities in the Pharmaceuticals industry
Empower your strategies with our Acostic Neuroma (Auditory Nerve Tumor) – Drugs In Development, 2024 report and make more profitable business decisions.
Acostic neuroma or vestibular schwannoma is a noncancerous, usually slow growing tumor affecting balance and auditory nerves. It is of two types: sporadic unilateral acoustic neuroma and genetic, bilateral acoustic neuroma. Hearing loss, dizziness, tinnitus, eye fullness, balance problems and vertigo, numbness in the face, and swallowing problems are some of the signs and symptoms. It can be diagnosed through audiometry and imaging of head. Surgery or stereotactic radiosurgery can be an effective treatment.
The Acostic Neuroma (Auditory Nerve Tumor) drugs in development market research report provide comprehensive information on the therapeutics under development for Acostic Neuroma (Auditory Nerve Tumor), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action and product description of the therapeutics, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Acostic Neuroma (Auditory Nerve Tumor) and features dormant and discontinued products.
Note:
* This is an “on-demand” report and will be delivered within 2 business days (excluding weekends and holidays) of the purchase.
* Certain sections in the report may be removed or altered based on the availability and relevance of data.
| Quick View – Acostic Neuroma (Auditory Nerve Tumor) | Key Targets |
|
|
| Key Mechanisms of Action |
|
||
| Key Routes of Administration |
|
||
| Key Molecule Types |
|
||
| Major Companies |
|
||
Scope
- Therapeutics in Development: Covering 6 molecules, with 5 developed by companies and the rest by universities/institutes.
- Analysis Parameters: Offering insights by stage of development, drug target, MoA, RoA, and molecule type for a comprehensive overview.
- Pharmacological Insights: Understand the descriptive pharmacological action of therapeutics.
- Development History: Access the complete research and development history.
- Latest News and Press Releases: Stay updated with the latest developments through comprehensive news coverage.
Reasons to Buy
- Holistic insights: Understand the broad spectrum of Acostic Neuroma (Auditory Nerve Tumor) therapeutics, aiding strategic decision-making with insights into stages, targets, MoA, RoA and molecule types.
- Pipeline Exploration: Explore the detailed Acostic Neuroma (Auditory Nerve Tumor) pipeline, offering nuanced analysis of drug targets, mechanisms of action and routes of administration for varied decision-making.
- Comprehensive R&D: Access thorough R&D histories, providing a comprehensive understanding of Acostic Neuroma (Auditory Nerve Tumor) treatments for adaptable decision-making.
- Save valuable hours: Identify key players steering innovation in therapeutics, enabling strategic partnerships.
Key Players
Akouos IncAstraZeneca Plc
Massachusetts Eye and Ear Infirmary
Millennium Pharmaceuticals Inc
Novartis AG
Recursion Pharmaceuticals Inc
Table of Contents
Table
Figures
Frequently asked questions
Related reports
View more Acostic Neuroma (Auditory Nerve Tumor) reports